Cordyceps for Fatigue

Verdict: Weak, indirect evidence for fatigue

Cordyceps earns a weak (Tier C) rating for fatigue: the limited human evidence is mostly indirect, drawn from small exercise-performance trials rather than studies measuring fatigue itself, so any benefit for everyday tiredness remains unproven.

C 🟠 C Weak Evidence Published

🔬Why this grade7-layer evidence engine

The grade is held down by both the type and size of the evidence. The supporting human data come from three small studies that measured exercise surrogates rather than fatigue directly. A 2025 meta-analysis in athletes (PMID 41280379, n=528) found only marginal endurance gains (p=0.05) plus modest improvements in ventilatory threshold and VO2peak, while two tiny double-blind RCTs (PMID 27408987, n=28; PMID 20804368, n=15) reported better time-to-exhaustion and metabolic thresholds. None measured everyday tiredness as a primary outcome.

Quality caveats compound the uncertainty: sample sizes are very small, doses and Cordyceps species differ across trials (sinensis vs militaris), and the Cs-4 product in PMID 20804368 was industry-supplied, raising a conflict-of-interest concern.

Authorities are largely unconvinced or silent. The EU EFSA assessed a Cordyceps energy/vitality claim and rejected it as not supported by pertinent human data. The Cleveland Clinic notes its traditional use for energy and fatigue but stresses that evidence is conflicting and more human trials are needed, while the NIH, Harvard, NHS and WHO do not endorse it for fatigue. That mix of weak surrogate data and a skeptical-to-absent expert consensus is why the rating stays at weak rather than moderate.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.57
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Published
Confidence
82%
Highly consistent evidence
Evidence level
E3
Single high-quality meta-analysis

How strongly each layer supports this effect

lower = less supportive
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.51
L2 PubMedPrimary literature
0.60
L3 MechanismPlausibility
0.65
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.569
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — | B→C 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (3)L2 · primary research & systematic reviews

Effects of fungal supplementation on endurance, immune function, and hematological profiles in adult athletes: a systematic review and meta-analysis
PMID: 41280379 2025 統合分析 n = 528
Finding: Cordyceps showed marginally significant endurance improvement (p=0.05) and significant gains in ventilatory threshold (p=0.03) and VO2peak (p=0.04), with low heterogeneity.
Academic
View on PubMed
Cordyceps militaris Improves Tolerance to High-Intensity Exercise After Acute and Chronic Supplementation
PMID: 27408987 2017 RCT (double-blind) n = 28
Finding: After 3 weeks TTE rose +69.8 s and VO2max +4.8 ml/kg/min (p=0.042); 1 week showed no significant effect.
🟠 Limited quality Government Effect size: MD +69.8 s TTE
View on PubMed
Effect of Cs-4 (Cordyceps sinensis) on exercise performance in healthy older subjects: a double-blind, placebo-controlled trial
PMID: 20804368 2010 RCT (double-blind) n = 15
Finding: Metabolic threshold +10.5% (p=0.022) and ventilatory threshold +8.5% (p=0.031) in Cs-4 group; no VO2max change.
🟠 Limited quality Mixed funding Effect size: MD +10.5% metabolic threshold
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
L4b EU EFSA
Against
Scientific Opinion Part II on the substantiation of health claims related to various food(s)/food constituent(s) not supported by pertinent human data (ID 406, 462, 472, 543, 659, 678, 696, 858, 1381, 1403, 1437, 1438, 1513, 1536, 1537, 1538, 1539, 1540, 1543, 1613, 1627, 1855, 1860, 1981, 2126, 2514, 3127, 4038, 4501, 4672, 4712, 4718) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 source↗
L4d TW TFDA / 衛福部
Supportive
「冬蟲夏草菌絲體食品標示相關規定」(食藥署101年2月9日署授食字第1001303885號公告,103年2月9日生效):含冬蟲夏草菌絲體之產品,應於明顯易見處加註『本產品非中藥材冬蟲夏草之製品』之醒語;應明確標示菌株之中文名稱及拉丁學名;品名應完整標示為『冬蟲夏草菌絲體』七個字,不得僅標示『冬蟲夏草』,且七個字字體大小一致;使用之菌株須為中華被毛孢(Hirsutella sinensis),或分離自冬蟲夏草之蟲草相關菌株。違規涉違反食安法第22條,依第47條處3萬至300萬元罰鍰。衛福部另說明:『目前核准3款含蟲草相關成分的健康食品』,『所核准的保健功效分別為抗疲勞、護肝及調節免疫』,3件產品皆經科學化安全及保健功效評估試驗。 source↗
L5c Cleveland Clinic
Cautious
Cordyceps have long been used in traditional Chinese medicine among older populations to provide energy, reduce fatigue and boost libido and sex drive. source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬3 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-fatigue-INT-cordyceps-001 繁體中文版 →